When was PolyPeptide founded?

PolyPeptide was founded in 1952.

Where is PolyPeptide located?

PolyPeptide is headquartered in Baar, Switzerland. It is registered at Torrance, California.

How many employees does PolyPeptide have?

As of Sep 30, 2026, the latest employee count at PolyPeptide is 1478.

Where does PolyPeptide rank among its competitors?

PolyPeptide ranks 3rd amongst 69 active competitors, of which 6 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Enzene, which secured $50M in Jan, 2023.

Who are the top competitors of PolyPeptide?

PolyPeptide's top competitors include AmbioPharm, Enzene and Shaanxi Micot Technology. Among them, Enzene secured the most recent funding round in January, 2023.

PolyPeptide - 2026 Company Profile & Competitors

PolyPeptide is a public company based in Baar (Switzerland), founded in 1952. It operates as a CMO manufacturing proprietary,GMP grade and non-GMP-grade peptides. The company has 69 active competitors, including 6 funded and 11 that have exited. Its top competitors include companies like AmbioPharm, Enzene and Shaanxi Micot Technology.

Company Details

PolyPeptide Labs is a CMO manufacturing proprietary (generally approved drug substances), GMP grade (for clinical trials) and non-GMP grade (small scale custom synthesis) - peptides for the pharmaceutical, cosmetic, biotechnology and veterinary markets. Using their synthetic technologies and methodologies, they manufacture peptides up to 80 amino acids in length and in quantities ranging from milligram/gram to multi-10kg quantities. Depending on the nature and quantity of the peptide needed, a solid phase, a classical liquid phase, or a hybrid approach is developed for manufacturing. They claim to manufacture over one-third of all approved peptide drug substances (22 of 62 approved products worldwide) accounting for over 25% of the sales of outsourced peptide therapeutics worldwide.

Website: polypeptide.com
Social
Email ID: *****@polypeptide.com
Phone Number: +41 **********
Registered Address: Torrance, California

Key Metrics

Founded Year

1952

Location

Baar, Switzerland

Stage

Public

Ranked

3^rd among 69 active competitors

Employee Count

1,478 as on Sep 30, 2026

Similar Companies

AmbioPharm & 77 more

Exit Details

Public

View PolyPeptide's full profile

PolyPeptide is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Polypeptide Laboratories Holding ( Ppl) Ab CIN: 0680.977.711 , Belgium, Active	Sep 13, 2017	-	-	-
POLYPEPTIDE LABORATORIES PRIVATE LIMITED CIN: U51397MH2001PTC130734 , India, Active	Feb 06, 2001	₹50 - ₹100 Cr (As on Mar 31, 2025)	98 (As on Mar 31, 2024)
POLYPEPTIDE LABORATORIES, INC. CIN: 954599892 , United States, Active	Dec 26, 999	-	254 (As on Dec 31, 2024)	-

PolyPeptide got listed on Apr 29, 2021.

Click here to take a look at PolyPeptide's IPO in detail

PolyPeptide has not raised any funding rounds yet.

PolyPeptide's employee count trend

PolyPeptide has 1,478 employees as of Sep 26. Here is PolyPeptide's employee count trend over the years:

Uncover PolyPeptide's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PolyPeptide include AmbioPharm, Enzene and Shaanxi Micot Technology. Here is the list of Top 10 competitors of PolyPeptide, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AmbioPharm 2006, North Augusta (United States), Acquired	Peptide manufacturing and development services, setting a new standard worldwide	$24M	The Carlyle Group, MVM & 1 others	58/100
2nd	Enzene 2015, Pune (India), Series C	Company specializing in development of Biosimilars	$50M	F-Prime Capital, Eight Roads Ventures & 1 others	55/100
3rd	PolyPeptide 1952, Baar (Switzerland), Public	CMO manufacturing proprietary,GMP grade and non-GMP-grade peptides	-	-	49/100
4th	Shaanxi Micot Technology 2007, China, Public	Provider of drug research and development services focused on cardiovascular and metabolic diseases	$72.2M	NLVC, Tasly & 2 others	49/100
5th	Hybio Pharmaceutical 1998, Shenzhen (China), Public	Developer and manufacturer of polypeptide drugs and APis	$15M	Shenzhen Capital Group, SAIF Partners & 1 others	43/100
6th	JPT Peptide 2004, Berlin (Germany), Acquired	Peptide based CRO offering proteomics, biomarker and drug discovery services	-	-	40/100
7th	Custom Peptide Synthesis 2011, Mumbai (India), Unfunded	Manufacturer of peptides and other finished formulations, & APIs	-	-	40/100
8th	Proteos Biotech 2010, Madrid (Spain), Unfunded	Manufacturer of recombinant enzymes and provides CMO services	-	-	38/100
9th	Rameda 1994, Giza (Egypt), Public	Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products	-	Public Investment Fund, Compass Capital	37/100
10th	CPC Scientific 2001, Sunnyvale (United States), Unfunded	Company offering peptide development and manufacturing services for clinical and commercial applications	-	-	36/100